223 related articles for article (PubMed ID: 15754169)
1. Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.
Olszewska E; Lautermann J; Koc C; Schwaab M; Dazert S; Hildmann H; Sudhoff H
Eur Arch Otorhinolaryngol; 2005 Sep; 262(9):731-6. PubMed ID: 15754169
[TBL] [Abstract][Full Text] [Related]
2. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
Olszewska E; Sudhoff H
Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
van Blitterswijk CA; Grote JJ
Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratins in induced epidermoid formations and cholesteatoma lesions.
Vennix PP; Kuijpers W; Tonnaer EL; Peters TA; Ramaekers FC
Arch Otolaryngol Head Neck Surg; 1990 May; 116(5):560-5. PubMed ID: 1691647
[TBL] [Abstract][Full Text] [Related]
7. [Middle ear cholesteatoma: present-day concepts of etiology and pathogenesis].
Lesinskas E; Kasinskas R; Vainutiene V
Medicina (Kaunas); 2002; 38(11):1066-71; quiz 1141. PubMed ID: 12532718
[TBL] [Abstract][Full Text] [Related]
8. [Epidermoid formation in the pathogenesis of congenital cholesteatoma--a current review].
Sudhoff H; Liang J; Dazert S; Borkowski G; Michaels L
Laryngorhinootologie; 1999 Feb; 78(2):63-7. PubMed ID: 10226987
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
11. An immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma.
Chao WY; Huang CC
Arch Otorhinolaryngol; 1989; 246(1):37-42. PubMed ID: 2472127
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma.
Persaud R; Hajioff D; Trinidade A; Khemani S; Bhattacharyya MN; Papadimitriou N; Kalan A; Bhattacharyya AK
J Laryngol Otol; 2007 Nov; 121(11):1013-9. PubMed ID: 17697435
[TBL] [Abstract][Full Text] [Related]
13. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
Feng YS; Si Y; Zhang ZG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
[TBL] [Abstract][Full Text] [Related]
14. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.
Broekaert D; Cornille A; Eto H; Leigh I; Ramaekers F; Van Muijen G; Coucke P; De Bersaques J; Kluyskens P; Gillis E
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):39-51. PubMed ID: 2453971
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of congenital cholesteatoma of the middle ear].
Kikuchi M; Yamamoto E; Shinohara S; Shiomi Y; Fujiwara K; Shiomi Y; Watanabe F; Tanabe M
Nihon Jibiinkoka Gakkai Kaiho; 2003 Aug; 106(8):797-807. PubMed ID: 14513775
[TBL] [Abstract][Full Text] [Related]
16. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
17. Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations.
Sudhoff H; Bujía J; Borkowshi G; Koc C; Holly A; Hildmann H; Fisseler-Eckhoff A
Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):804-10. PubMed ID: 8865776
[TBL] [Abstract][Full Text] [Related]
18. Air-exposed tissue culture of human middle ear epithelium and meatal epidermis: a method to study the advancing front of cholesteatoma.
Albers-op t' Hof BM; Peek FA; Huisman MA; Grote JJ
Acta Otolaryngol; 2002 Oct; 122(7):720-5. PubMed ID: 12484648
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
20. [Altered cytokeratin expression of the epidermoid formation in the tympanic cavity of human fetuses].
Huang J; Yi Z; Lin G
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(2):72-4. PubMed ID: 9387495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
